Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jan;8(1):11-13.
doi: 10.1016/S2213-8587(19)30381-X. Epub 2019 Dec 5.

BPA: have flawed analytical techniques compromised risk assessments?

Roy Gerona  1 , Frederick S Vom Saal  2 , Patricia A Hunt  3
Affiliations

BPA: have flawed analytical techniques compromised risk assessments?

Roy Gerona et al. Lancet Diabetes Endocrinol. 2020 Jan.
No abstract available

PubMed Disclaimer

Comment in

  • BPA and risk assessment.
    Calafat AM, Koch HM; additional coauthors. Calafat AM, et al. Lancet Diabetes Endocrinol. 2020 Apr;8(4):269-270. doi: 10.1016/S2213-8587(20)30070-X. Lancet Diabetes Endocrinol. 2020. PMID: 32197109 Free PMC article. No abstract available.
  • BPA and risk assessment.
    Palmer K, Speirs V. Palmer K, et al. Lancet Diabetes Endocrinol. 2020 Apr;8(4):269. doi: 10.1016/S2213-8587(20)30068-1. Lancet Diabetes Endocrinol. 2020. PMID: 32197110 No abstract available.
  • BPA and risk assessment.
    Dupuis A, Rabouan S, Migeot V, Venisse N. Dupuis A, et al. Lancet Diabetes Endocrinol. 2020 Apr;8(4):270-271. doi: 10.1016/S2213-8587(20)30069-3. Lancet Diabetes Endocrinol. 2020. PMID: 32197111 No abstract available.
  • BPA and risk assessment - Authors' reply.
    Hunt PA, Vom Saal FS, Stahlhut R, Gerona R. Hunt PA, et al. Lancet Diabetes Endocrinol. 2020 Apr;8(4):271-272. doi: 10.1016/S2213-8587(20)30071-1. Lancet Diabetes Endocrinol. 2020. PMID: 32197112 No abstract available.

Publication types

LinkOut - more resources